Repousser les limites de la kératoplastie endothéliale

Mon statut pour la session

Quand:

1:30 PM, Dimanche 3 Juin 2018 (1 heure 30 minutes)

Pauses:

Pause 03:00 PM à 03:45 PM (45 minutes)

Où:

Metro Toronto Convention Centre (Édifice Sud) - Salle 714 A

Thème:

Cornée

OBJECTIFS D'APPRENTISSAGE
À la fin de la session, les participants pourront :

Évaluer les nouvelles données probantes dans le domaine de la kératoplastie endothéliale
Décrire l’application élargie des techniques à des scénarios plus complexes
Décrire les autres techniques possibles pour aborder la kératoplastie endothéliale

RÔLES CANMEDS: Érudit, expert médical

Kashif Baig, MD, MBA, FRCSC

Modérateur.rice

Dr. Soosan Jacob, MS, FRCS, DNB, MNAMS

Participant.e

Dr. Alfonso Iovieno, MD, PhD, FRCSC, FACS

Autre participant.e

Sous sessions

Introduction

1:30 PM - 1:32 PM | 2 minutes

Topical ganciclovir for prophylaxis of cytomegalovirus endotheliitis in endothelial keratoplasty

1:32 PM - 1:37 PM | 5 minutes

Authors: Alfred Basilious, Hall Chew Author Disclosure Block: A. Basilious: None. H. Chew: None. Abstract Body: Purpose: To describe the presentation and management of two cases of DSEK with subsequent failure secondary to CMV infection and prophylaxis with topical ganciclovir to prevent repeat DMEK failure. Study Design: Retrospective case series Methods: A chart review was conducted for 2 patients (2 eyes) with...

Dr. Alfred Basilious

Participant.e

Discussion

1:37 PM - 1:40 PM | 3 minutes

What I do differently X years after learning DSAEK

1:40 PM - 1:50 PM | 10 minutes

Dr. Mahshad Darvish

Participant.e

What I do differently X years after learning DMEK

1:50 PM - 2:00 PM | 10 minutes

Dr. Johanna Choremis, MD, FRCSC, DABO

Participant.e

Discussion

2:00 PM - 2:05 PM | 5 minutes

DMEK in patients with previous trabeculectomy or tube shunt

2:05 PM - 2:10 PM | 5 minutes

Authors: Tanguy Boutin, Nir Sorkin, Adi Einan Lifshitz, Zale Mednick, Mahmood Showail, Armand Borovik, Clara C. Chan, David Rootman Author Disclosure Block: T. Boutin: None. N. Sorkin: None. A. Einan Lifshitz: None. Z. Mednick: None. M. Showail: None. A. Borovik: None. C.C. Chan: None. D. Rootman: None. Abstract Body: Purpose: To present the outcome of Descemet Membrane Endothelial Ke...

Dr. Tanguy Boutin MSc, MD, FRCSC

Participant.e

DMEK for management of rare and complex anterior segment disease

2:10 PM - 2:15 PM | 5 minutes

Authors: Samir Jabbour, Julia Talajic, Michèle Mabon, Johanna Choremis Author Disclosure Block: S. Jabbour: None. J. Talajic: None. M. Mabon: None. J. Choremis: None. Abstract Body: Purpose: Very few reports have been published on the feasibility of DMEK in complex anterior segment disease. The scientific literature remains very scarce on the safety an efficacy of DMEK in rare anterior segment disease. In this case series, we report our exp...